Laboratory risk factors for thrombosis in 109 women with a history of VTE
| Risk factors . | Abnormality/total . | Percentage . |
|---|---|---|
| None | 39 of 101* | 39.0 |
| Heterozygous factor V:R506Q | 38 of 109 | 35.0 |
| Homozygous factor V:R506Q | 5 of 109 | 4.6 |
| Heterozygous G20210A prothrombin | 8 of 107 | 7.5 |
| Antithrombin deficiency | 2 of 109 | 1.8 |
| Protein C deficiency | 5 of 109 | 4.6 |
| Protein S deficiency | 5 of 109 | 4.6 |
| Hyperhomocystinemia | 11 of 101 | 11.0 |
| Elevated factor VIII | 12 of 102 | 12.0 |
| Lupus anticoagulant | 3 of 109 | 2.8 |
| Of these | ||
| Two risk factors combined | 13 of 101* | 13.0 |
| Three risk factors combined | 3 of 101* | 3.0 |
| Risk factors . | Abnormality/total . | Percentage . |
|---|---|---|
| None | 39 of 101* | 39.0 |
| Heterozygous factor V:R506Q | 38 of 109 | 35.0 |
| Homozygous factor V:R506Q | 5 of 109 | 4.6 |
| Heterozygous G20210A prothrombin | 8 of 107 | 7.5 |
| Antithrombin deficiency | 2 of 109 | 1.8 |
| Protein C deficiency | 5 of 109 | 4.6 |
| Protein S deficiency | 5 of 109 | 4.6 |
| Hyperhomocystinemia | 11 of 101 | 11.0 |
| Elevated factor VIII | 12 of 102 | 12.0 |
| Lupus anticoagulant | 3 of 109 | 2.8 |
| Of these | ||
| Two risk factors combined | 13 of 101* | 13.0 |
| Three risk factors combined | 3 of 101* | 3.0 |
In 101 women, all risk factors were determined.